Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $16.94 billion. The enterprise value is $16.09 billion.
| Market Cap | 16.94B |
| Enterprise Value | 16.09B |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026, after market close.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 100.55 million shares outstanding. The number of shares has decreased by -0.68% in one year.
| Current Share Class | 100.55M |
| Shares Outstanding | 100.55M |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 102.70% |
| Float | 99.30M |
Valuation Ratios
The trailing PE ratio is 25.92 and the forward PE ratio is 14.95. NBIX's PEG ratio is 0.31.
| PE Ratio | 25.92 |
| Forward PE | 14.95 |
| PS Ratio | 5.46 |
| Forward PS | 4.24 |
| PB Ratio | 4.98 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | 20.38 |
| P/OCF Ratio | 19.62 |
| PEG Ratio | 0.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.42, with an EV/FCF ratio of 19.36.
| EV / Earnings | 24.07 |
| EV / Sales | 5.19 |
| EV / EBITDA | 19.42 |
| EV / EBIT | 20.15 |
| EV / FCF | 19.36 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.93 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 0.56 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 22.50% and return on invested capital (ROIC) is 23.74%.
| Return on Equity (ROE) | 22.50% |
| Return on Assets (ROA) | 11.62% |
| Return on Invested Capital (ROIC) | 23.74% |
| Return on Capital Employed (ROCE) | 19.60% |
| Weighted Average Cost of Capital (WACC) | 6.26% |
| Revenue Per Employee | $1.55M |
| Profits Per Employee | $334,300 |
| Employee Count | 2,000 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 17.89 |
Taxes
In the past 12 months, NBIX has paid $268.90 million in taxes.
| Income Tax | 268.90M |
| Effective Tax Rate | 28.68% |
Stock Price Statistics
The stock price has increased by +31.88% in the last 52 weeks. The beta is 0.40, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +31.88% |
| 50-Day Moving Average | 151.00 |
| 200-Day Moving Average | 141.85 |
| Relative Strength Index (RSI) | 64.14 |
| Average Volume (20 Days) | 1,268,298 |
Short Selling Information
The latest short interest is 5.53 million, so 5.50% of the outstanding shares have been sold short.
| Short Interest | 5.53M |
| Short Previous Month | 5.16M |
| Short % of Shares Out | 5.50% |
| Short % of Float | 5.57% |
| Short Ratio (days to cover) | 4.28 |
Income Statement
In the last 12 months, NBIX had revenue of $3.10 billion and earned $668.60 million in profits. Earnings per share was $6.50.
| Revenue | 3.10B |
| Gross Profit | 2.00B |
| Operating Income | 798.80M |
| Pretax Income | 937.50M |
| Net Income | 668.60M |
| EBITDA | 828.60M |
| EBIT | 798.80M |
| Earnings Per Share (EPS) | $6.50 |
Balance Sheet
The company has $1.32 billion in cash and $463.50 million in debt, giving a net cash position of $852.70 million or $8.48 per share.
| Cash & Cash Equivalents | 1.32B |
| Total Debt | 463.50M |
| Net Cash | 852.70M |
| Net Cash Per Share | $8.48 |
| Equity (Book Value) | 3.41B |
| Book Value Per Share | 33.87 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was $863.70 million and capital expenditures -$32.40 million, giving a free cash flow of $831.30 million.
| Operating Cash Flow | 863.70M |
| Capital Expenditures | -32.40M |
| Depreciation & Amortization | 29.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 831.30M |
| FCF Per Share | $8.27 |
Margins
Gross margin is 64.37%, with operating and profit margins of 25.75% and 21.55%.
| Gross Margin | 64.37% |
| Operating Margin | 25.75% |
| Pretax Margin | 30.22% |
| Profit Margin | 21.55% |
| EBITDA Margin | 26.71% |
| EBIT Margin | 25.75% |
| FCF Margin | 26.80% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 0.68% |
| Earnings Yield | 3.95% |
| FCF Yield | 4.91% |
Analyst Forecast
The average price target for NBIX is $194.38, which is 15.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $194.38 |
| Price Target Difference | 15.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 20.54% |
| EPS Growth Forecast (3Y) | 36.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 6.99 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.99 |
| Piotroski F-Score | 6 |